These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10410712)

  • 1. Glutamate receptor-mediated mechanisms in levodopa-induced motor fluctuations in an experimental model of parkinsonism.
    Marin C; Tolosa E
    Adv Neurol; 1999; 80():129-33. PubMed ID: 10410712
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.
    Maranis S; Stamatis D; Tsironis C; Konitsiotis S
    Eur J Pharmacol; 2012 May; 683(1-3):71-7. PubMed ID: 22410193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.
    Wessell RH; Ahmed SM; Menniti FS; Dunbar GL; Chase TN; Oh JD
    Neuropharmacology; 2004 Aug; 47(2):184-94. PubMed ID: 15223297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats.
    Gilgun-Sherki Y; Melamed E; Ziv I; Offen D
    Pharmacol Toxicol; 2003 Jul; 93(1):54-6. PubMed ID: 12828575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Buccofacial dyskinesia of iatrogenic origin].
    Reynes P; Guichard M; Guiraud P
    Rev Odontostomatol (Paris); 1983; 12(6):461-9. PubMed ID: 6142519
    [No Abstract]   [Full Text] [Related]  

  • 6. Narrow beneficial effect of dextromethorphan on levodopa-induced motor response alterations in an experimental model of parkinsonism.
    Jiménez A; Marin C; Bonastre M; Tolosa E
    Brain Res; 1999 Aug; 839(1):190-3. PubMed ID: 10482813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.
    Encarnacion EV; Hauser RA
    Eur Neurol; 2008; 60(2):57-66. PubMed ID: 18480609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
    Rylander D; Iderberg H; Li Q; Dekundy A; Zhang J; Li H; Baishen R; Danysz W; Bezard E; Cenci MA
    Neurobiol Dis; 2010 Sep; 39(3):352-61. PubMed ID: 20452425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
    J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys.
    Papa SM; Chase TN
    Ann Neurol; 1996 May; 39(5):574-8. PubMed ID: 8619541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism.
    Klintenberg R; Svenningsson P; Gunne L; Andrén PE
    J Neural Transm (Vienna); 2002 Oct; 109(10):1295-307. PubMed ID: 12373562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improper treatment of patients with parkinsonism due to drug use].
    Meerwaldt JD; Staal A
    Ned Tijdschr Geneeskd; 1982 Jul; 126(28):1257-9. PubMed ID: 7133158
    [No Abstract]   [Full Text] [Related]  

  • 15. Glutamate release inhibition ineffective in levodopa-induced motor complications.
    Bara-Jimenez W; Dimitrova TD; Sherzai A; Aksu M; Chase TN
    Mov Disord; 2006 Sep; 21(9):1380-3. PubMed ID: 16758479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?
    Konitsiotis S; Tsironis C
    Behav Brain Res; 2006 Jun; 170(2):337-41. PubMed ID: 16621050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.
    Kobylecki C; Crossman AR; Ravenscroft P
    Exp Neurol; 2013 Sep; 247():476-84. PubMed ID: 23360800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating levodopa-induced dyskinesias in the parkinsonian primate.
    Langston JW; Quik M; Petzinger G; Jakowec M; Di Monte DA
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S79-89. PubMed ID: 10762135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
    Bezard E; Tronci E; Pioli EY; Li Q; Porras G; Björklund A; Carta M
    Mov Disord; 2013 Jul; 28(8):1088-96. PubMed ID: 23389842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sustained levodopa efficacy in parkinsonism. Results of a four-year long-term follow-up study (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Nervenarzt; 1977 Apr; 48(4):205-10. PubMed ID: 404579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.